Amphetamine activates non-receptor tyrosine kinase Fyn and stimulates ERK phosphorylation in the rat striatum in vivo

Eur J Pharmacol. 2019 Jan 15:843:45-54. doi: 10.1016/j.ejphar.2018.11.006. Epub 2018 Nov 9.

Abstract

The psychostimulant amphetamine (AMPH) has an impact on a variety of cellular activities in striatal neurons, although underlying signaling mechanisms are incompletely understood. The Src family kinase (SFK) is among key signaling molecules enriched in striatal neurons and is involved in the regulation of a set of discrete downstream targets. Given the likelihood that AMPH may regulate SFKs, we investigated and characterized the effect of AMPH on SFK phosphorylation and enzymatic activity in rat striatal neurons in vivo. We found that AMPH elevated SFK Y416 phosphorylation in striatal slices and the adult rat striatum. This elevation was concentration- and time-dependent and occurred in all subdivisions of the striatum, including the caudate putamen and nucleus accumbens (core and shell). The dopamine D1 receptor antagonist SCH23390 blocked the effect of AMPH. Between Fyn and Src, AMPH elevated phosphorylation of immunoprecipitated Fyn but not Src and increased Fyn kinase activity in the striatum. In parallel with SFKs, striatal ERK phosphorylation was increased by AMPH. This increase in ERK phosphorylation was reduced by the SFK inhibitor PP2. These results demonstrate that AMPH is able to activate SFKs (mainly Fyn) in striatal neurons via a D1 receptor-dependent mechanism. Activated SFKs participate in processing the concomitant ERK response to AMPH.

Keywords: Caudate putamen; Dopamine D(1) receptor; ERK; Nucleus accumbens; Src; Tyrosine kinase.

MeSH terms

  • Amphetamine / pharmacology*
  • Animals
  • Benzazepines / pharmacology
  • Central Nervous System Stimulants / pharmacology*
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Dopamine Antagonists / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Male
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-fyn / metabolism*
  • Rats, Wistar
  • Receptors, Dopamine D1 / antagonists & inhibitors

Substances

  • Benzazepines
  • Central Nervous System Stimulants
  • Dopamine Antagonists
  • Receptors, Dopamine D1
  • SCH 23390
  • Amphetamine
  • Fyn protein, rat
  • Proto-Oncogene Proteins c-fyn
  • Extracellular Signal-Regulated MAP Kinases